Zelltek is a company dedicated to the development, production, and commercialization of biosimilar health products. It is currently owned by the Amega Biotech Group (www.amegabiotech.com). The main products are biopharmaceuticals obtained by culturing recombinant host cells, such as bacteria and mammalian cells. Zelltek activates in a very sensitive domain, storing critical information such as research and development processes, intellectual property, chemical recipes, etc. A data leak would be disastrous, causing customer loss, reputation damage and loss of competitive advantage. In addition, condential information resides on laptops and desktop computers in various parts of the country, determining the need for remote control of removable devices. The systems department tested

Join for free to read